Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 108

    1.

    Medical marijuana users in substance abuse treatment.

    Swartz R.

    Harm Reduct J. 2010 Mar 5;7:3.

    PMID:
    20202221
    [PubMed]
    Free PMC Article
    2.

    Final Report on Carcinogens Background Document for Formaldehyde.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.

    PMID:
    20737003
    [PubMed - as supplied by publisher]
    3.

    Final Report on Carcinogens Background Document for Styrene.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.

    PMID:
    20737009
    [PubMed - as supplied by publisher]
    4.

    [Cannabis and schizophrenia: demographic and clinical correlates].

    Dervaux A, Laqueille X, Bourdel MC, Leborgne MH, Olié JP, Lôo H, Krebs MO.

    Encephale. 2003 Jan-Feb;29(1):11-7. French.

    PMID:
    12640322
    [PubMed - indexed for MEDLINE]
    5.

    Treatment response by primary drug of abuse: does methamphetamine make a difference?

    Luchansky B, Krupski A, Stark K.

    J Subst Abuse Treat. 2007 Jan;32(1):89-96. Epub 2006 Sep 7.

    PMID:
    17175402
    [PubMed - indexed for MEDLINE]
    6.

    [Motivational interviewing for cannabis users with psychotic disorders].

    Bonsack C, Montagrin Y, Favrod J, Gibellini S, Conus P.

    Encephale. 2007 Oct;33(5):819-26. French.

    PMID:
    18357854
    [PubMed - indexed for MEDLINE]
    7.

    High prevalence of substance use disorders among adolescents who use marijuana and inhalants.

    Wu LT, Pilowsky DJ, Schlenger WE.

    Drug Alcohol Depend. 2005 Apr 4;78(1):23-32.

    PMID:
    15769554
    [PubMed - indexed for MEDLINE]
    8.

    The Adolescent Substance Abuse Prevention Study: A randomized field trial of a universal substance abuse prevention program.

    Sloboda Z, Stephens RC, Stephens PC, Grey SF, Teasdale B, Hawthorne RD, Williams J, Marquette JF.

    Drug Alcohol Depend. 2009 Jun 1;102(1-3):1-10. Epub 2009 Mar 29.

    PMID:
    19332365
    [PubMed - indexed for MEDLINE]
    9.

    Costs and effectiveness of substance abuse treatments for homeless persons.

    Schumacher JE, Mennemeyer ST, Milby JB, Wallace D, Nolan K.

    J Ment Health Policy Econ. 2002 Mar;5(1):33-42.

    PMID:
    12529568
    [PubMed - indexed for MEDLINE]
    10.

    Characteristics and problems of 600 adolescent cannabis abusers in outpatient treatment.

    Tims FM, Dennis ML, Hamilton N, J Buchan B, Diamond G, Funk R, Brantley LB.

    Addiction. 2002 Dec;97 Suppl 1:46-57.

    PMID:
    12460128
    [PubMed - indexed for MEDLINE]
    12.

    [Contributions of parental and social influences to cannabis use in a non-clinical sample of adolescents].

    Chabrol H, Mabila JD, Chauchard E, Mantoulan R, Rousseau A.

    Encephale. 2008 Jan;34(1):8-16. Epub 2007 Sep 4. French.

    PMID:
    18514145
    [PubMed - indexed for MEDLINE]
    13.

    Mothers in substance abuse treatment: differences in characteristics based on involvement with child welfare services.

    Grella CE, Hser YI, Huang YC.

    Child Abuse Negl. 2006 Jan;30(1):55-73. Epub 2006 Jan 6.

    PMID:
    16406024
    [PubMed - indexed for MEDLINE]
    14.

    Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders.

    Crowley TJ, Macdonald MJ, Whitmore EA, Mikulich SK.

    Drug Alcohol Depend. 1998 Mar 1;50(1):27-37.

    PMID:
    9589270
    [PubMed - indexed for MEDLINE]
    15.

    Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.

    Marshall M, Crowther R, Almaraz-Serrano A, Creed F, Sledge W, Kluiter H, Roberts C, Hill E, Wiersma D, Bond GR, Huxley P, Tyrer P.

    Health Technol Assess. 2001;5(21):1-75. Review.

    PMID:
    11532238
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    Factor structures for DSM-IV substance disorder criteria endorsed by alcohol, cannabis, cocaine and opiate users: results from the WHO reliability and validity study.

    Nelson CB, Rehm J, Ustün TB, Grant B, Chatterji S.

    Addiction. 1999 Jun;94(6):843-55.

    PMID:
    10665074
    [PubMed - indexed for MEDLINE]
    17.

    Marijuana use and treatment outcome among opioid-dependent patients.

    Budney AJ, Bickel WK, Amass L.

    Addiction. 1998 Apr;93(4):493-503.

    PMID:
    9684388
    [PubMed - indexed for MEDLINE]
    18.

    [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].

    Guillem E, Pelissolo A, Vorspan F, Bouchez-Arbabzadeh S, Lépine JP.

    Encephale. 2009 Jun;35(3):226-33. Epub 2008 Aug 19. French.

    PMID:
    19540408
    [PubMed - indexed for MEDLINE]
    19.
    20.

    [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].

    Goeb JL, Coste J, Bigot T, Ferrand I.

    Encephale. 2000 Nov-Dec;26(6):11-20. French.

    PMID:
    11217533
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk